Dysplasia of the Tricuspid Valve Leading to Recurrent Atrial Flutter and Fibrillation: a Case Report

Overview

Journal Eur Heart J Case Rep

Publisher Oxford University Press

Specialty Cardiology & Vascular Diseases

Date 2025 Jan 3

PMID 39748933

Authors

Taemi Yoshida

Edmund Gatterer

Andreas Strouhal

Marieluise Harrer

Claudia Stollberger

Affiliations

Soon will be listed here.

Abstract

Background: Atrial flutter (AFL) is usually effectively treated by cavotricuspid isthmus (CTI) ablation. If AFL recurs despite ablation, there is risk of progression to atrial fibrillation (AF) and clinicians should consider underlying structural heart diseases. This consideration becomes especially critical when right-heart-chambers are dilated.

Case Summary: A 50-year-old man presented with palpitations due to AFL. Fifteen years earlier, after polytrauma, mild tricuspid regurgitation (TR) and pericardial effusion had been diagnosed on transthoracic echocardiography (TTE). At present, TTE showed dilated right-heart-chambers and moderate TR. Despite two CTI-ablations, he developed AF for which he underwent pulmonary vein isolation (PVI). A further ablation was performed because of right-sided AFL due to transcrista conduction. Atrial fibrillation recurred, accompanied by heart failure. Tricuspid regurgitation severity and right-heart-chamber dilatation worsened. Finally, 3D-transoesophageal echocardiography (3D-TEE), performed 20 years after the first TTE, revealed that TR was due to restriction of the septal leaflet. The patient underwent surgery. The tricuspid valve was repaired by ring annuloplasty and a cleft between the anterior and septal leaflets was closed. Three years post-operatively, he is asymptomatic with chronic AF but no recurrent AFL. Transthoracic echocardiography shows only mild TR, though the right-heart-chambers remain dilated, likely due to long-standing TR.

Discussion: Tricuspid regurgitation and AFL/AF have a bidirectional relationship. Tricuspid regurgitation can both cause and result from AFL/AF. Structural heart diseases, including post-traumatic valve damage, should be considered in patients with recurrent AFL despite CTI-ablation and progression to AF. In cases with TR and right-heart-chamber enlargement, 3D-TEE is essential for accurate diagnosis and should be performed without delay.

References

Shibata T, Takahashi Y, Fujii H, Morisaki A, Abe Y . Surgical considerations for atrial functional regurgitation of the mitral and tricuspid valves based on the etiological mechanism. Gen Thorac Cardiovasc Surg. 2021; 69(7):1041-1049. PMC: 8203518. DOI: 10.1007/s11748-021-01629-x. View

Karaca O, Demir G, Ozyuksel A, Akcevin A . Tricuspid valve chordal rupture after a motorbike accident. Turk Kardiyol Dern Ars. 2016; 44(4):329-31. DOI: 10.5543/tkda.2015.76573. View

Martin de Miguel I, Miranda W, Madhavan M, Connolly H, Dearani J, Egbe A . Risk Factors for Atrial Arrhythmias in Adults With Ebstein Anomaly. JACC Adv. 2024; 1(3):100058. PMC: 11198643. DOI: 10.1016/j.jacadv.2022.100058. View

Partington S, Kilner P . How to Image the Dilated Right Ventricle. Circ Cardiovasc Imaging. 2017; 10(5). DOI: 10.1161/CIRCIMAGING.116.004688. View

Brugada J, Katritsis D, Arbelo E, Arribas F, Bax J, Blomstrom-Lundqvist C . 2019 ESC Guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC). Eur Heart J. 2019; 41(5):655-720. DOI: 10.1093/eurheartj/ehz467. View

Van Gelder I, Rienstra M, Bunting K, Casado-Arroyo R, Caso V, Crijns H . 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2024; 45(36):3314-3414. DOI: 10.1093/eurheartj/ehae176. View

Otomo K, Okamura H, Noda T, Satomi K, Shimizu W, Suyama K . Site-specific influence of transversal conduction across crista terminalis on recognition of isthmus block. Pacing Clin Electrophysiol. 2006; 29(6):589-99. DOI: 10.1111/j.1540-8159.2006.00383.x. View

Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J . 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2021; 43(7):561-632. DOI: 10.1093/eurheartj/ehab395. View

Rimawi A, Rimawi A . Successful Radiofrequency Ablation of an Atrial Flutter in an Elderly Patient With Uncorrected Ebstein's Anomaly. Cureus. 2021; 12(12):e12242. PMC: 7822633. DOI: 10.7759/cureus.12242. View

Kakuda N, Nakayama A, Ishizuka M, Takeda N, Morita H, Itoda Y . Delayed diagnosis of severe traumatic tricuspid regurgitation after traffic injury. J Cardiol Cases. 2022; 25(4):204-206. PMC: 9325988. DOI: 10.1016/j.jccase.2021.09.009. View

10.

Hiram R, Naud P, Xiong F, Al-Udatt D, Algalarrondo V, Sirois M . Right Atrial Mechanisms of Atrial Fibrillation in a Rat Model of Right Heart Disease. J Am Coll Cardiol. 2019; 74(10):1332-1347. DOI: 10.1016/j.jacc.2019.06.066. View

11.

Loutati R, Katz A, Segev A, Kuperstein R, Sabbag A, Maor E . A decade of follow-up: atrial fibrillation, pulmonary pressure, and the progression of tricuspid regurgitation. Eur Heart J Qual Care Clin Outcomes. 2024; . DOI: 10.1093/ehjqcco/qcae075. View

12.

Faletra F, Leo L, Paiocchi V, Schlossbauer S, Borruso M, Pedrazzini G . Imaging-based tricuspid valve anatomy by computed tomography, magnetic resonance imaging, two and three-dimensional echocardiography: correlation with anatomic specimen. Eur Heart J Cardiovasc Imaging. 2018; 20(1):1-13. DOI: 10.1093/ehjci/jey136. View

13.

Dechering D, Gonska B, Brachmann J, Lewalter T, Kuck K, Andresen D . Efficacy and complications of cavo-tricuspid isthmus-dependent atrial flutter ablation in patients with and without structural heart disease: results from the German Ablation Registry. J Interv Card Electrophysiol. 2020; 61(1):55-62. DOI: 10.1007/s10840-020-00769-z. View

14.

Cardona-Guarache R, Astrom-Aneq M, Oesterle A, Asirvatham R, Svetlichnaya J, Marcus G . Atrial arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy: Prevalence, echocardiographic predictors, and treatment. J Cardiovasc Electrophysiol. 2019; 30(10):1801-1810. DOI: 10.1111/jce.14069. View